ATP binding cassette transporter G5 and G8 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin (Q28236930)

5

object named as

Ernst J Schaefer

0 references

author name string

Kouji Kajinami

1

0 references

Margaret E Brousseau

2

0 references

Chorthip Nartsupha

Journal of Lipid Research

3

0 references

language of work or name

English

0 references

publication date

April 2004

0 references

published in

0 references

volume

45

0 references

issue

4

0 references

page(s)

653-6

0 references

cites work

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300278-JLR200

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300278-JLR200

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300278-JLR200

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300278-JLR200

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300278-JLR200

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300278-JLR200

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300278-JLR200

Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300278-JLR200

Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300278-JLR200

ATP binding cassette G5 C1950G polymorphism may affect blood cholesterol concentrations in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300278-JLR200

Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300278-JLR200

Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300278-JLR200

Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300278-JLR200

Sluggish sitosterol turnover and hepatic failure to excrete sitosterol into bile cause expansion of body pool of sitosterol in patients with sitosterolemia and xanthomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300278-JLR200

Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300278-JLR200